ArticleScientific reports2024

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia.

Zachary C Rosenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.